Recurrent erythema multiforme in the setting of COVID-19 infection and oral candidiasis: A case for dysregulation of the T helper 17/interleukin 17 axis
Saved in:
Main Authors: | Rebekah M. Leigh, BS (Author), Luke Horton, MD (Author), Bonnie A. Lee, MD (Author), Michelle S. Min, MD, MS (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of recurrent erythema multiforme with adalimumab as monotherapy
by: Bryan Baillis, MD, et al.
Published: (2017) -
Recurrent bullous erythema multiforme due to oral contraceptive therapy
by: Afsoon Ghafari-Saravi, BS, et al.
Published: (2024) -
Erythema multiforme after initiation of anti interleukin-12/23 (ustekinumab) treatment for plaque psoriasis
by: Martina Burlando, MD, et al.
Published: (2020) -
Erythema multiforme associated with Entamoeba histolytica
by: Karyn Haitz, MD, et al.
Published: (2021) -
A Case Report of Erythema Multiforme
by: Md Mohaiminul Islam, et al.
Published: (2019)